Pharmacy World and Science

, Volume 25, Issue 6, pp 247–250 | Cite as

Drug information in psychiatric hospitals in Flanders: a study of patient-oriented leaflets

  • Lieven Zwaenepoel
  • Gert Laekeman


Objective: This study reviews written information sources that inform patients about their drugs used in psychiatric institutions in Flanders.Methods: Pharmacists working in psychiatry were asked to participate. Seven leaflets were collected and evaluated using the Flesh readability formula and twelve hospital pharmacists scored ten propositions on a Likert scale. Questionnaires were mailed to the participants.Results: There was wide variation within the three readability parameters: reading ease varied from easy to difficult, personal interest from tedious/scientific to very interesting/illustrated magazines and the quick reading test varied from formal to very popular. Two brochures were tedious and formal. As to the content, only three were significantly considered ‘very interesting for patients’ (P < 0.05). Most were found to be clear and not too long. Concrete information about administration, dosage and duration of therapy appeared to be absent from several leaflets. Adverse effects and possible complications were thought to be well rendered in most screened sources. According to the respondents, the role of the pharmacist was not sufficiently mentioned.Conclusion: Only three leaflets appeared to be suitable as a patient-oriented information tool. Pharmacists in psychiatric institutions can contribute to patient counselling by providing high-quality leaflets.

Belgium Hospital Information leaflets Psychiatry 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43.Google Scholar
  2. 2.
    Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care settings: evidence and recommendations for future research. Ann Pharmacother 1999; 33: 1336–55.Google Scholar
  3. 3.
    Hardin TC, Reed WE, Talbert RL, Hightower WL. Physicians' perceptions of a clinical pharmacy program. Am J Hosp Pharm 1982; 39: 125–6.Google Scholar
  4. 4.
    Cohen LJ. The role of neuropsychiatric pharmacists. J Clin Psychiatry 1999; 60 (Suppl 19): 54–7.Google Scholar
  5. 5.
    Aström K, Carlsson J, Bates I, Webb DG, Duggan C, Sanghani P, McRobbie D. Desire for information about drugs, a multimethod study in general medical inpatients. Pharm World Sci 2000; 22(4): 159–64.Google Scholar
  6. 6.
    Laekeman G, Leemans L. Communicatie in de apotheek. Leuven/Amersfoort, The Netherlands: Acco; 1999.Google Scholar
  7. 7.
    Zondag CHJ, Blom ATG, Broekam WJ, Leemans L, Martens EP, Schobben AFAM. Geneesmiddeleninformatie op een psychiatrische afdeling. De introductie en het effect. Pharm Weekbl 2002; 137(11): 390–6.Google Scholar
  8. 8.
    Laekeman G, Reyntens J, De Vos M, Bilo R, De Boever W, Van den Berghe M et al. Neuropharmacology for psychiatric pharmacists: a continuing education program for Belgian clinical pharmacists. ESCP Spring Conference on Clinical Pharmacy, May 11– 13, 2000, Reykjavik, Iceland.Google Scholar

Copyright information

© Kluwer Academic Publishers 2003

Authors and Affiliations

  • Lieven Zwaenepoel
    • 1
  • Gert Laekeman
  1. 1.Division of Drug and Patient Information, Faculty of Pharmaceutical SciencesCatholic University of LeuvenLeuvenBelgium

Personalised recommendations